IL118469A - Naphthalene derivatives their preparation and intermediates thereof - Google Patents
Naphthalene derivatives their preparation and intermediates thereofInfo
- Publication number
- IL118469A IL118469A IL11846996A IL11846996A IL118469A IL 118469 A IL118469 A IL 118469A IL 11846996 A IL11846996 A IL 11846996A IL 11846996 A IL11846996 A IL 11846996A IL 118469 A IL118469 A IL 118469A
- Authority
- IL
- Israel
- Prior art keywords
- intermediates
- preparation
- naphthalene derivatives
- naphthalene
- derivatives
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title 1
- 150000002790 naphthalenes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14928895 | 1995-06-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL118469A0 IL118469A0 (en) | 1996-09-12 |
IL118469A true IL118469A (en) | 2000-08-13 |
Family
ID=15471914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11846996A IL118469A (en) | 1995-06-15 | 1996-05-30 | Naphthalene derivatives their preparation and intermediates thereof |
Country Status (21)
Country | Link |
---|---|
US (3) | US6005106A (hu) |
EP (1) | EP0748805B1 (hu) |
KR (1) | KR100435247B1 (hu) |
CN (1) | CN1063748C (hu) |
AR (1) | AR002483A1 (hu) |
AT (1) | ATE164843T1 (hu) |
AU (1) | AU706156B2 (hu) |
BG (1) | BG62521B1 (hu) |
BR (1) | BR9602802A (hu) |
CA (1) | CA2178974C (hu) |
DE (1) | DE69600221T2 (hu) |
ES (1) | ES2116131T3 (hu) |
HK (1) | HK1010116A1 (hu) |
HU (1) | HU222340B1 (hu) |
IL (1) | IL118469A (hu) |
MY (1) | MY121606A (hu) |
NO (1) | NO310109B1 (hu) |
RU (1) | RU2129120C1 (hu) |
SG (1) | SG47152A1 (hu) |
TW (1) | TW349098B (hu) |
ZA (1) | ZA964652B (hu) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID19155A (id) * | 1996-12-13 | 1998-06-18 | Tanabe Seiyaku Co | Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya |
JPH1171351A (ja) * | 1997-08-29 | 1999-03-16 | Ss Pharmaceut Co Ltd | 置換キノロン誘導体及びこれを含有する医薬 |
DE69939629D1 (de) | 1998-05-05 | 2008-11-06 | Massachusetts Inst Technology | Emittierende Polymere und Vorrichtungen diese Polymere enthaltend |
US20050147534A1 (en) | 1998-05-05 | 2005-07-07 | Massachusetts Institute Of Technology | Emissive sensors and devices incorporating these sensors |
PT1212089E (pt) | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Combinacao sinergica de roflumilast e salmeterol |
KR20040007596A (ko) * | 2001-05-23 | 2004-01-24 | 다나베 세이야꾸 가부시키가이샤 | 골절 치료 촉진용 조성물 |
CA2447618A1 (en) * | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | A composition for regenerative treatment of cartilage disease |
TWI221838B (en) | 2001-08-09 | 2004-10-11 | Tanabe Seiyaku Co | Pyrazinoisoquinoline compound or naphthalene compound |
CA2468544A1 (en) * | 2001-12-10 | 2003-06-19 | Amgen Inc. | Vanilloid receptor ligands |
WO2003057689A1 (en) * | 2002-01-02 | 2003-07-17 | Fujisawa Pharmaceutical Co., Ltd. | Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them |
PL375552A1 (en) * | 2002-05-22 | 2005-11-28 | Amgen Inc. | Vanilloid receptor ligands and their medical applications |
WO2004014871A1 (en) * | 2002-08-08 | 2004-02-19 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
EP1604981A4 (en) | 2003-03-14 | 2008-12-24 | Ono Pharmaceutical Co | NITROGENIC HETEROCYCLIC DERIVATIVES AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE |
MXPA05010373A (es) | 2003-04-01 | 2005-12-05 | Applied Research Systems | Inhibidores de fosfodiesterasas en infertilidad. |
JP2007516095A (ja) * | 2003-05-16 | 2007-06-21 | ユニヴァーシティ・オヴ・シカゴ | 光学分別装置および光学分別方法 |
AU2004278382B2 (en) * | 2003-09-30 | 2008-09-18 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
EP1745034A1 (en) * | 2004-02-11 | 2007-01-24 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
MY139645A (en) * | 2004-02-11 | 2009-10-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
NZ553696A (en) | 2004-09-13 | 2010-02-26 | Ono Pharmaceutical Co | Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
WO2006034081A2 (en) | 2004-09-17 | 2006-03-30 | Massachusetts Institute Of Technology | Polymers for analyte detection |
TWI339578B (en) | 2004-10-29 | 2011-04-01 | Mitsubishi Tanabe Pharma Corp | Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
WO2006089311A1 (en) * | 2005-02-15 | 2006-08-24 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
WO2006113769A1 (en) * | 2005-04-15 | 2006-10-26 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
US7972836B2 (en) | 2005-10-04 | 2011-07-05 | Mitsubishi Tanabe Pharma Corporation | Method of enzymatic optical resolution of racemic 4-hydroxy-1,2,3,4-tetrahydroquinoline |
PT1944291E (pt) | 2005-10-04 | 2012-08-10 | Mitsubishi Tanabe Pharma Corp | Álcool cíclico opticamente activo e método para a sua produção |
EP1941881B1 (en) * | 2005-10-05 | 2014-08-13 | Mitsubishi Tanabe Pharma Corporation | Naphthalene derivatives for the treatment of dermatitis and psoriasis |
EA200870344A1 (ru) | 2006-03-10 | 2009-04-28 | Оно Фармасьютикал Ко., Лтд. | Азотсодержащее гетероциклическое производное и фармацевтическое средство, включающее такое производное в качестве активного ингредиента |
WO2007112347A1 (en) * | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2008042289A2 (en) | 2006-09-29 | 2008-04-10 | Massachusetts Institute Of Technology | Polymer synthetic technique |
US8802447B2 (en) | 2006-10-05 | 2014-08-12 | Massachusetts Institute Of Technology | Emissive compositions with internal standard and related techniques |
US20090215189A1 (en) | 2006-10-27 | 2009-08-27 | Massachusetts Institute Of Technology | Sensor of species including toxins and chemical warfare agents |
EP1958947A1 (en) * | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
JP2010524857A (ja) * | 2007-04-10 | 2010-07-22 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | フェン−ナフタレン及びフェン−キノリン誘導体、及びアミロイドプラークに結合させ、そして造影するための使用 |
US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
ES2659458T3 (es) * | 2011-06-28 | 2018-03-15 | Mitsubishi Tanabe Pharma Corporation | Compuestos de naftaleno para tratar el prurito |
EP2749558A4 (en) | 2011-08-25 | 2014-11-19 | Mitsubishi Tanabe Pharma Corp | PROCESS FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND |
US11970440B1 (en) | 2023-10-30 | 2024-04-30 | King Faisal University | 8-(3-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound |
US11932593B1 (en) | 2023-10-31 | 2024-03-19 | King Faisal University | 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound |
US11987543B1 (en) | 2023-10-31 | 2024-05-21 | King Faisal University | 8-(4-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3042156B2 (ja) * | 1992-02-20 | 2000-05-15 | 田辺製薬株式会社 | ナフタレン誘導体、その製法及びその合成中間体 |
US5342841A (en) * | 1992-03-12 | 1994-08-30 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
EP0731084B1 (de) * | 1995-03-03 | 2002-09-25 | Rolic AG | Photovernetzbare Naphthylderivate |
-
1996
- 1996-05-30 IL IL11846996A patent/IL118469A/xx not_active IP Right Cessation
- 1996-05-31 TW TW085106502A patent/TW349098B/zh not_active IP Right Cessation
- 1996-06-03 MY MYPI96002135A patent/MY121606A/en unknown
- 1996-06-04 AT AT96304033T patent/ATE164843T1/de active
- 1996-06-04 AU AU54693/96A patent/AU706156B2/en not_active Expired
- 1996-06-04 DE DE69600221T patent/DE69600221T2/de not_active Expired - Lifetime
- 1996-06-04 EP EP96304033A patent/EP0748805B1/en not_active Expired - Lifetime
- 1996-06-04 ES ES96304033T patent/ES2116131T3/es not_active Expired - Lifetime
- 1996-06-11 SG SG1996010041A patent/SG47152A1/en unknown
- 1996-06-12 BG BG100656A patent/BG62521B1/bg unknown
- 1996-06-14 RU RU96112130A patent/RU2129120C1/ru active
- 1996-06-14 AR ARP960103158A patent/AR002483A1/es not_active Application Discontinuation
- 1996-06-14 CA CA002178974A patent/CA2178974C/en not_active Expired - Lifetime
- 1996-06-14 NO NO962527A patent/NO310109B1/no not_active IP Right Cessation
- 1996-06-14 BR BRPI9602802-5A patent/BR9602802A/pt not_active IP Right Cessation
- 1996-06-14 US US08/663,991 patent/US6005106A/en not_active Expired - Lifetime
- 1996-06-14 HU HU9601652A patent/HU222340B1/hu active IP Right Grant
- 1996-06-15 KR KR1019960021677A patent/KR100435247B1/ko active IP Right Grant
- 1996-06-15 ZA ZA964652A patent/ZA964652B/xx unknown
- 1996-06-17 CN CN96106608A patent/CN1063748C/zh not_active Expired - Lifetime
-
1998
- 1998-07-02 US US09/109,099 patent/US5969140A/en not_active Expired - Lifetime
- 1998-09-24 HK HK98110940A patent/HK1010116A1/xx not_active IP Right Cessation
- 1998-12-01 US US09/201,820 patent/US6214996B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR100435247B1 (ko) | 2004-09-10 |
BG100656A (en) | 1997-09-30 |
CA2178974C (en) | 2006-06-06 |
ES2116131T3 (es) | 1998-07-01 |
SG47152A1 (en) | 1998-03-20 |
HU222340B1 (hu) | 2003-06-28 |
CN1063748C (zh) | 2001-03-28 |
AU706156B2 (en) | 1999-06-10 |
EP0748805B1 (en) | 1998-04-08 |
CA2178974A1 (en) | 1996-12-16 |
HUP9601652A1 (en) | 1997-09-29 |
US6005106A (en) | 1999-12-21 |
BR9602802A (pt) | 1998-10-06 |
ZA964652B (en) | 1996-12-12 |
US6214996B1 (en) | 2001-04-10 |
HK1010116A1 (en) | 1999-06-11 |
ATE164843T1 (de) | 1998-04-15 |
DE69600221D1 (de) | 1998-05-14 |
AR002483A1 (es) | 1998-03-25 |
NO310109B1 (no) | 2001-05-21 |
CN1142497A (zh) | 1997-02-12 |
HU9601652D0 (en) | 1996-08-28 |
EP0748805A1 (en) | 1996-12-18 |
DE69600221T2 (de) | 1998-08-06 |
MY121606A (en) | 2006-02-28 |
BG62521B1 (bg) | 2000-01-31 |
NO962527L (no) | 1996-12-16 |
US5969140A (en) | 1999-10-19 |
RU2129120C1 (ru) | 1999-04-20 |
IL118469A0 (en) | 1996-09-12 |
KR970001343A (ko) | 1997-01-24 |
NO962527D0 (no) | 1996-06-14 |
TW349098B (en) | 1999-01-01 |
AU5469396A (en) | 1997-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL118469A (en) | Naphthalene derivatives their preparation and intermediates thereof | |
IL118825A (en) | Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use | |
IL116851A0 (en) | 3-arylidene-2-oxindole derivatives their preparation and use | |
IL119864A0 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use | |
KR19987002466A (en) | Pyrazol-4-yl-benzoyl derivatives and their use as herbicides | |
IL116325A0 (en) | Substituted 1h-imidazoles their preparation and use | |
ZA966494B (en) | New drugs and their use | |
IL118442A0 (en) | Triazolymethyl-cyclopentanols their preparation and use | |
IL118380A0 (en) | Substituted pyridine derivatives their preparation and use | |
IL122216A0 (en) | Dolastatin derivatives their preparation and use | |
IL114795A0 (en) | N-benzylindole- and benmzopyrazole derivatives their preparation and use | |
IL118441A0 (en) | Triazolymethyl-oxiranes their preparation and use | |
NZ300198A (en) | Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines | |
IL118443A0 (en) | Cycloalkane-benzylidene derivatives their preparation and use | |
IL118295A0 (en) | 3-(2- trialkylsilyloxy) ethyl-7-ethyl-1H- indoles and their preparation | |
IL116710A0 (en) | Substituted 2-phenylpyridines their preparation and use | |
IL116712A0 (en) | Substituted 2-phenylpyridines their preparation and use | |
IL123092A0 (en) | Pyrazol-4-ylbenzoyl derivatives their preparation and use | |
IL122342A0 (en) | Retinoid derivatives and their use | |
AU4459196A (en) | Sustained-release preparation and use | |
GR3033729T3 (en) | Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides | |
IL116711A0 (en) | Substituted 2-phenylpyridines their preparation and use | |
IL118444A0 (en) | Mercapto-triazolyl-silanes their preparation and use | |
IL122686A0 (en) | Benzylhydroxylamines their preparation and use | |
EP0833835A4 (en) | OBESITY PROTEIN INTERMEDIATE PRODUCTS, THEIR PRODUCTION AND USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |